Cite
Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment.
MLA
Al-Hatamleh, Mohammad A. I., et al. “Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment.” Cells (2073-4409), vol. 9, no. 1, Jan. 2020, pp. 1–16. EBSCOhost, https://doi.org/10.3390/cells9010033.
APA
Al-Hatamleh, M. A. I., E. A. R., E. N. S., Boer, J. C., Ferji, K., Six, J.-L., Xin Chen, Elkord, E., Plebanski, M., & Mohamud, R. (2020). Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment. Cells (2073-4409), 9(1), 1–16. https://doi.org/10.3390/cells9010033
Chicago
Al-Hatamleh, Mohammad A. I., Engku Nur Syafirah E. A. R., Jennifer C. Boer, Khalid Ferji, Jean-Luc Six, Xin Chen, Eyad Elkord, Magdalena Plebanski, and Rohimah Mohamud. 2020. “Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment.” Cells (2073-4409) 9 (1): 1–16. doi:10.3390/cells9010033.